Facilitated By

San Antonio Medical Foundation

A TREATMENT PROTOCOL TO ALLOW PATIENTS IN THE US WITH IDIOPATHIC PULMONARY FIBROSIS ACCESS TO PIRFENIDONE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Nambiar,Anoop
Funded by
INTERMUNE PHARMACEUTICALS
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Aging